COMPRIX 2026: Submission Phase Now Open
The submission phase for COMPRIX 2026 has begun! Submit your projects now and showcase creative excellence in healthcare communication.
Image: COMPRIX GbR
Tomas Mihal appointed new Head of STADA Germany
STADA has appointed Tomas Mihal as its new Head of Germany and member of the global STADA Executive Committee. The experienced manager will further strengthen the company’s position and drive sustainable growth across all three business segments.
Health 2025: Mental Health and GLP-1 in Focus
The new Ipsos Health Service Report 2025 reveals that mental health remains the world’s biggest health concern, while social media drives new narratives around GLP-1 drugs like Ozempic and Mounjaro.
Open Run Club Hamburg launches with Techniker Krankenkasse
Running together instead of alone: The Open Run Club Hamburg by RUNNER’S WORLD and Techniker Krankenkasse invites everyone to join community runs around the Alster – for those seeking motivation, fun, and connection.
10 Years of the Health-i Award: AI Transforms Healthcare
The Health-i Award celebrates its 10th anniversary by honoring visionary start-ups that are shaping the future of medicine through Artificial Intelligence.
Beurer Wins the German Health Award 2025
Beurer has once again been recognized at the German Health Award 2025, winning two top honors for outstanding customer satisfaction and product quality.
Adrian Haack joins WEFRA LIFE Management Board
Starting October 2025, Adrian Haack will join the WEFRA LIFE management board. With his international experience, he will drive the agency group’s growth, innovation, and AI transformation.
BeOne Medicines appoints Walter Hafian-Hatzenbichler as Director of Corporate Affairs Germany
BeOne Medicines has permanently appointed Walter Gerhard Hafian-Hatzenbichler as Director of Corporate Affairs Germany. He will oversee the company’s strategic communications and public affairs in Germany.
Rethinking Asthma: Modern Therapies Instead of Steroid Tablets
Many people with severe asthma still rely on steroid tablets – despite modern alternatives. AstraZeneca is now raising nationwide awareness about effective biologic therapies.
Grünhorn launches integrated platform for cannabis therapy
Grünhorn evolves from a pharmacy to an integrated cannabis therapy platform – combining digital care, professional education, and a strong patient community.